Mark Jeffrey DeLong - 22 Jan 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Mark DeLong
Issuer symbol
APLS
Transactions as of
22 Jan 2025
Net transactions value
-$42,474
Form type
4
Filing time
23 Jan 2025, 15:23:36 UTC
Previous filing
21 Jan 2025
Next filing
30 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $42,474 -1,396 -1.6% $30.43 84,673 22 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 21, 2025.